Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Mimedx (MDXG) over the last 16 years, with Q3 2025 value amounting to -$5.3 million.

  • Mimedx's Cash from Investing Activities fell 475309.73% to -$5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.3 million, marking a year-over-year decrease of 2769.63%. This contributed to the annual value of -$9.6 million for FY2024, which is 34468.68% down from last year.
  • Mimedx's Cash from Investing Activities amounted to -$5.3 million in Q3 2025, which was down 475309.73% from -$887000.0 recorded in Q2 2025.
  • In the past 5 years, Mimedx's Cash from Investing Activities ranged from a high of $113000.0 in Q3 2024 and a low of -$6.0 million during Q1 2024
  • Over the past 5 years, Mimedx's median Cash from Investing Activities value was -$580000.0 (recorded in 2021), while the average stood at -$1.3 million.
  • As far as peak fluctuations go, Mimedx's Cash from Investing Activities soared by 11741.14% in 2024, and later tumbled by 475309.73% in 2025.
  • Quarter analysis of 5 years shows Mimedx's Cash from Investing Activities stood at -$314000.0 in 2021, then crashed by 444.27% to -$1.7 million in 2022, then soared by 71.85% to -$481000.0 in 2023, then crashed by 475.26% to -$2.8 million in 2024, then crashed by 90.03% to -$5.3 million in 2025.
  • Its Cash from Investing Activities was -$5.3 million in Q3 2025, compared to -$887000.0 in Q2 2025 and -$406000.0 in Q1 2025.